 Alia Al-Tayyib
Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Substance Abuse, Intravenous | 9 | 2020 | 99 | 2.640 |
Why?
| | Opioid-Related Disorders | 7 | 2022 | 413 | 1.630 |
Why?
| | Homosexuality, Male | 7 | 2022 | 170 | 1.540 |
Why?
| | Hepatitis C | 6 | 2023 | 219 | 1.060 |
Why?
| | Prescription Drug Misuse | 2 | 2017 | 38 | 1.000 |
Why?
| | HIV Infections | 16 | 2022 | 2469 | 0.940 |
Why?
| | Heroin Dependence | 2 | 2017 | 22 | 0.920 |
Why?
| | Sexual Behavior | 8 | 2022 | 440 | 0.870 |
Why?
| | Unsafe Sex | 3 | 2017 | 58 | 0.680 |
Why?
| | Gonorrhea | 3 | 2012 | 54 | 0.660 |
Why?
| | Drug Overdose | 3 | 2020 | 292 | 0.630 |
Why?
| | Buprenorphine | 1 | 2021 | 134 | 0.620 |
Why?
| | Analgesics, Opioid | 5 | 2022 | 771 | 0.600 |
Why?
| | Substance-Related Disorders | 4 | 2020 | 947 | 0.590 |
Why?
| | Emergency Service, Hospital | 10 | 2023 | 1815 | 0.570 |
Why?
| | Amphetamine-Related Disorders | 1 | 2017 | 28 | 0.550 |
Why?
| | Mobile Applications | 1 | 2017 | 141 | 0.470 |
Why?
| | Prescription Drugs | 1 | 2016 | 116 | 0.470 |
Why?
| | Mass Screening | 9 | 2023 | 1004 | 0.450 |
Why?
| | Chlamydia Infections | 3 | 2012 | 65 | 0.450 |
Why?
| | Homeless Youth | 1 | 2013 | 15 | 0.440 |
Why?
| | Health Services Needs and Demand | 1 | 2015 | 243 | 0.420 |
Why?
| | Adult | 30 | 2023 | 30550 | 0.410 |
Why?
| | Internet | 1 | 2017 | 596 | 0.410 |
Why?
| | Colorado | 10 | 2020 | 4099 | 0.410 |
Why?
| | Primary Prevention | 1 | 2014 | 172 | 0.400 |
Why?
| | Public Health | 1 | 2016 | 433 | 0.390 |
Why?
| | Health Knowledge, Attitudes, Practice | 4 | 2020 | 1183 | 0.390 |
Why?
| | Social Stigma | 2 | 2022 | 87 | 0.370 |
Why?
| | Male | 34 | 2022 | 55599 | 0.350 |
Why?
| | Methadone | 1 | 2011 | 77 | 0.340 |
Why?
| | Comorbidity | 3 | 2021 | 1448 | 0.340 |
Why?
| | Young Adult | 15 | 2022 | 10470 | 0.340 |
Why?
| | Opiate Substitution Treatment | 2 | 2021 | 98 | 0.330 |
Why?
| | Sexual Partners | 3 | 2018 | 161 | 0.330 |
Why?
| | Prevalence | 6 | 2019 | 2251 | 0.320 |
Why?
| | Attitude | 1 | 2011 | 229 | 0.320 |
Why?
| | Heterosexuality | 3 | 2018 | 29 | 0.320 |
Why?
| | Hepacivirus | 4 | 2023 | 229 | 0.320 |
Why?
| | Safety-net Providers | 2 | 2020 | 95 | 0.310 |
Why?
| | Health Services Accessibility | 3 | 2022 | 763 | 0.310 |
Why?
| | Telephone | 2 | 2009 | 152 | 0.310 |
Why?
| | Heroin | 2 | 2020 | 23 | 0.310 |
Why?
| | Adolescent | 17 | 2021 | 17848 | 0.310 |
Why?
| | Methamphetamine | 2 | 2020 | 51 | 0.300 |
Why?
| | Middle Aged | 19 | 2021 | 26737 | 0.290 |
Why?
| | Humans | 39 | 2023 | 114689 | 0.270 |
Why?
| | Self Disclosure | 2 | 2009 | 59 | 0.270 |
Why?
| | Female | 28 | 2022 | 59511 | 0.260 |
Why?
| | Risk-Taking | 4 | 2020 | 333 | 0.240 |
Why?
| | United States | 15 | 2022 | 12183 | 0.230 |
Why?
| | Surveys and Questionnaires | 3 | 2017 | 4623 | 0.220 |
Why?
| | Cities | 3 | 2020 | 80 | 0.220 |
Why?
| | Behavioral Risk Factor Surveillance System | 4 | 2017 | 44 | 0.220 |
Why?
| | Socioeconomic Factors | 6 | 2020 | 1078 | 0.220 |
Why?
| | Insurance, Health | 2 | 2015 | 244 | 0.200 |
Why?
| | Family Planning Services | 1 | 2022 | 68 | 0.190 |
Why?
| | Needle Sharing | 1 | 2020 | 9 | 0.180 |
Why?
| | Needle-Exchange Programs | 1 | 2020 | 7 | 0.180 |
Why?
| | Risk | 2 | 2016 | 812 | 0.170 |
Why?
| | Sexual and Gender Minorities | 1 | 2022 | 138 | 0.170 |
Why?
| | Allied Health Personnel | 1 | 2020 | 42 | 0.170 |
Why?
| | Drug Users | 1 | 2020 | 41 | 0.170 |
Why?
| | Interviews as Topic | 2 | 2014 | 583 | 0.160 |
Why?
| | Washington | 2 | 2020 | 134 | 0.160 |
Why?
| | Baltimore | 2 | 2008 | 43 | 0.150 |
Why?
| | HIV | 3 | 2019 | 208 | 0.150 |
Why?
| | Pre-Exposure Prophylaxis | 1 | 2020 | 179 | 0.150 |
Why?
| | Patient Acceptance of Health Care | 2 | 2012 | 681 | 0.130 |
Why?
| | Machine Learning | 1 | 2020 | 316 | 0.130 |
Why?
| | Patient Participation | 1 | 2019 | 359 | 0.130 |
Why?
| | Condoms | 2 | 2014 | 113 | 0.130 |
Why?
| | Interpersonal Relations | 1 | 2018 | 341 | 0.120 |
Why?
| | Reproductive Health | 1 | 2015 | 71 | 0.120 |
Why?
| | Adolescent Behavior | 1 | 2020 | 489 | 0.120 |
Why?
| | Patient Protection and Affordable Care Act | 1 | 2015 | 99 | 0.120 |
Why?
| | Public Health Surveillance | 1 | 2015 | 61 | 0.120 |
Why?
| | Health Care Reform | 1 | 2015 | 92 | 0.120 |
Why?
| | Emergency Medical Services | 2 | 2020 | 590 | 0.120 |
Why?
| | Insurance Coverage | 2 | 2015 | 200 | 0.120 |
Why?
| | Sexually Transmitted Diseases | 1 | 2015 | 155 | 0.110 |
Why?
| | Contact Tracing | 1 | 2012 | 16 | 0.100 |
Why?
| | Sex Factors | 1 | 2017 | 1715 | 0.100 |
Why?
| | AIDS Serodiagnosis | 1 | 2012 | 29 | 0.100 |
Why?
| | Hepatitis C Antibodies | 1 | 2011 | 9 | 0.100 |
Why?
| | Clinical Laboratory Techniques | 1 | 2011 | 87 | 0.090 |
Why?
| | Health Promotion | 1 | 2017 | 686 | 0.090 |
Why?
| | Multivariate Analysis | 1 | 2014 | 1430 | 0.090 |
Why?
| | Urban Population | 2 | 2012 | 397 | 0.080 |
Why?
| | ROC Curve | 1 | 2011 | 442 | 0.080 |
Why?
| | Prospective Studies | 5 | 2023 | 6220 | 0.080 |
Why?
| | Cross-Sectional Studies | 2 | 2011 | 4410 | 0.080 |
Why?
| | Decision Support Techniques | 1 | 2013 | 355 | 0.080 |
Why?
| | Neisseria gonorrhoeae | 1 | 2008 | 20 | 0.080 |
Why?
| | Chlamydia trachomatis | 1 | 2008 | 36 | 0.080 |
Why?
| | Treatment Outcome | 3 | 2023 | 9088 | 0.070 |
Why?
| | Risk Assessment | 1 | 2015 | 2968 | 0.060 |
Why?
| | Bias | 1 | 2005 | 179 | 0.060 |
Why?
| | Age Factors | 2 | 2009 | 2894 | 0.060 |
Why?
| | Logistic Models | 1 | 2008 | 1841 | 0.050 |
Why?
| | Data Collection | 1 | 2005 | 620 | 0.050 |
Why?
| | Sex Education | 1 | 2022 | 30 | 0.050 |
Why?
| | Pregnancy, Unplanned | 1 | 2022 | 33 | 0.050 |
Why?
| | Intention to Treat Analysis | 1 | 2021 | 68 | 0.050 |
Why?
| | Contraception | 1 | 2022 | 117 | 0.050 |
Why?
| | Aged | 2 | 2016 | 19074 | 0.050 |
Why?
| | Algorithms | 1 | 2008 | 1469 | 0.050 |
Why?
| | Oregon | 1 | 2020 | 66 | 0.040 |
Why?
| | Costs and Cost Analysis | 1 | 2020 | 196 | 0.040 |
Why?
| | Inpatients | 1 | 2022 | 380 | 0.040 |
Why?
| | Odds Ratio | 1 | 2021 | 953 | 0.040 |
Why?
| | Drug Prescriptions | 1 | 2020 | 239 | 0.040 |
Why?
| | Family | 1 | 2022 | 589 | 0.040 |
Why?
| | Gender Identity | 1 | 2018 | 102 | 0.040 |
Why?
| | Self Efficacy | 1 | 2020 | 355 | 0.030 |
Why?
| | Medicaid | 1 | 2020 | 407 | 0.030 |
Why?
| | Minority Groups | 1 | 2018 | 227 | 0.030 |
Why?
| | Electronic Health Records | 1 | 2022 | 800 | 0.030 |
Why?
| | Delivery of Health Care | 1 | 2022 | 833 | 0.030 |
Why?
| | Health Status | 1 | 2020 | 722 | 0.030 |
Why?
| | Censuses | 1 | 2015 | 18 | 0.030 |
Why?
| | Cohort Studies | 2 | 2015 | 4895 | 0.030 |
Why?
| | Alcoholism | 1 | 2020 | 713 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2019 | 645 | 0.030 |
Why?
| | Phylogeny | 1 | 2017 | 789 | 0.030 |
Why?
| | Research Design | 1 | 2019 | 928 | 0.030 |
Why?
| | Risk Factors | 2 | 2019 | 8632 | 0.030 |
Why?
| | Medical Assistance | 1 | 2012 | 13 | 0.030 |
Why?
| | Hospitalization | 1 | 2020 | 1752 | 0.020 |
Why?
| | Hospitals, Urban | 1 | 2012 | 127 | 0.020 |
Why?
| | Cost-Benefit Analysis | 1 | 2013 | 544 | 0.020 |
Why?
| | Guidelines as Topic | 1 | 2012 | 243 | 0.020 |
Why?
| | Child | 2 | 2020 | 18415 | 0.020 |
Why?
| | Pregnancy | 1 | 2022 | 5518 | 0.020 |
Why?
| | Comprehension | 1 | 2012 | 156 | 0.020 |
Why?
| | Saliva | 1 | 2011 | 188 | 0.020 |
Why?
| | Triage | 1 | 2012 | 199 | 0.020 |
Why?
| | Hepatitis C, Chronic | 1 | 2011 | 151 | 0.020 |
Why?
| | Computers | 1 | 2009 | 60 | 0.020 |
Why?
| | Population Surveillance | 1 | 2011 | 392 | 0.020 |
Why?
| | Sexual Dysfunction, Physiological | 1 | 2009 | 60 | 0.020 |
Why?
| | Contraception Behavior | 1 | 2009 | 81 | 0.020 |
Why?
| | User-Computer Interface | 1 | 2009 | 140 | 0.020 |
Why?
| | Clinical Trials as Topic | 1 | 2012 | 932 | 0.020 |
Why?
| | Health Surveys | 1 | 2009 | 443 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2011 | 1693 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2013 | 2765 | 0.020 |
Why?
|
|
Al-Tayyib's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|